Default – 4 Column

Emerging researcher appointed to James Packer Chair in Mood Disorders at UNSW

The UNSW Discipline of Psychiatry and Mental Health is widely renowned as the pre-eminent psychiatry research department in the country and one of the leading university psychiatry research groups internationally. In 2023 it celebrated 60 Years of Psychiatry & Mental Health at UNSW Sydney.
Australian Health Journal spoke with Professor Kimberlie Dean, Head of the Discipline of Psychiatry and Mental Health at UNSW Sydney, about the recent appointment of mental health disorders expert and clinician researcher Dr Aswin Ratheesh to lead the James Packer Chair in Mood Disorders at UNSW Sydney.

New option for management of high-risk soft tissue sarcoma of the limb

SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.

Surgical Site Infection (SSI) Synopsis, including modifiable and non-modifiable risk factors

Talking to the Australian Health Journal, Professor Russo states there is a particular concern in joint operations, such as hip or knee replacements, as infections in these areas can have severe consequences, including the removal of the infected joint, prolonged treatment, and significant costs for both hospitals and patients. Despite the substantial impact of surgical site infections, Australia lacks a national surveillance program for these infections, making it challenging to obtain accurate data. However, an estimate suggests that around 45,000 surgical site infections occur annually in Australia, resulting in approximately 900 deaths.

Intervention in hearing loss for patients 

In her role as an audiologist and trainer, Lauren McNee emphasises the urgency of addressing sudden hearing loss, highlighting the time-sensitive nature of available treatment options. She advises healthcare professionals, including GPs, pharmacists, primary care nurses and specialists, to remain vigilant for subtle signs of hearing loss in their patients. Such signs may include difficulty following prescription guidelines, miscommunication during conversations, or non-verbal cues like a tilt of the head or asking for repetitions.

New treatment options under investigation for pelvic organ prolapse

Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.

Nurse led micro-suction earwax removal service continues success

At the 2024 Telstra Best of Business Awards in February, Earworx was recognised as the National Championing Health Award winner. Lisa Hellwege, the Clinical Director and Founder of Earworx, expressed her gratitude to the entire team and their patients for their trust and support. Earworx specialises in providing professional earwax removal services led by trained nurses using a procedure called microsuction.

Elevating Professional Standards in the Medtech and Pharmaceutical Sector

ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.

Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”

1 million Australians with undiagnosed thyroid disorders remain at risk of irreparable damage

The Australian Thyroid Foundation is a national not-for-profit organisation with charity status aimed at patients and the healthcare community.  The ATF’s focus is to support and educate its member base and promote our Good Thyroid Health Messaging throughout the Australian Community. 

Australian Thyroid Foundation, CEO Beverley Garside attending the breakfast gave her response to the Federal Budget and the Foundation’s pre-budget submission, which was not granted.

Scroll to top